Daewoong Pharmaceutical says, 'No problem with its Nabota exports to U.S.'
Daewoong Pharmaceutical says, 'No problem with its Nabota exports to U.S.'
  • Kim Min-jee
  • 승인 2019.03.06 05:20
  • 댓글 0
이 기사를 공유합니다

To make active response to the International Trade Commission (ITC) lawsuit

Regarding Allergan and Medytox's filing with the U.S. International Trade Commission (ITC) in January to block sales of Nabota (DWP-450, Jeuveau in the U.S.), Daewoong Pharmaceutical Co. announced on March 4 that they should take responsibility for groundless allegations.

Daewoong said, "The ITC lawsuit is part of the typical market defense strategy when competing products are released in the U.S. The charges raised by the plaintiffs in this lawsuit are no different from the claims made in the previous civil lawsuit."

It added that the application was received in a lawsuit that decides whether or not intellectual property rights are infringed in accordance with the U.S. Customs Law and it is a routine procedure to determine the opinions presented by both sides.
According to related industries, the Food and Drug Administration (FDA) rejected the Medytox-led petition made on Feb. 1 (local time) with the same content as ITC complaint.

The FDA said in an answer that it found no fraudulent activity that could be suspected of being false in the official statement of the Daewong Pharmaceutical.

"The lawsuit is nothing more than a groundless fiction as shown in the FDA's answer to the petition," a Daewoong official said. "We are confident that it will not affect the Navota exports to the U.S. at all."

Meanwhile, Daewong Pharmaceutical said Nabota will be released in the U.S. this spring as scheduled, following the FDA approval for the sale.


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • Korea IT Times: Copyright(C) 2004, Korea IT Times. .Allrights reserved.
  • #1206, 36-4 Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea(Postal Code 07331)
  • 서울특별시 영등포구 여의도동 36-4 (국제금융로8길 34) / 오륜빌딩 1206호
  • * Mobile News: m.koreaittimes.com
  • * Internet news: www.koreaittimes.com
  • * Editorial Div. 02-578-0434 / 010-2442-9446 * PR Global/AD: 82-2-578-0678.
  • * IT Times Canada: Willow St. Vancouver BC
  • 070-7008-0005
  • * Email: info@koreaittimes.com
ND소프트